The impact of the CD34+ cell dose on engraftment in allogeneic peripheral blood stem cell transplantation

By Ilhan O.   Arslan O.   Arat M.   Beksac M.   Akan H.   Ozcan M.   Gurman G.   Konuk N.   Uysal A.   Koc H.  

Transfusion and Apheresis Science, Vol. 20, Iss. 1, 1999-02 ,pp. : 69-71

Elsevier

Access to resources Recommend Favorite

The impact of the CD34+ cell dose on engraftment in allogeneic peripheral blood stem cell transplantation

By Ilhan O.   Arslan O.   Arat M.   Beksac M.   Akan H.   Ozcan M.   Gurman G.   Konuk N.   Uysal A.   Koc H.  

Transfusion Science, Vol. 20, Iss. 1, 1999-02 ,pp. : 69-71

Elsevier

Access to resources Recommend Favorite

Viable CD34+/CD133+ blood progenitor cell dose as a predictor of haematopoietic engraftment in multiple myeloma patients undergoing autologous peripheral blood stem cell transplantation

By Hicks C.   Wong R.   Manoharan A.   Kwan Y.  

Annals of Hematology, Vol. 86, Iss. 8, 2007-08 ,pp. : 591-598

Springer Publishing Company

Access to resources Recommend Favorite

Early peripheral T-cell expansion after haploidentical CD34 + peripheral blood progenitor cell transplantation (PBPCT) with T-cell depletion in a patient with X-linked SCID: case report

By Kalwak K.   Gorczynska E.   Toporski J.   Turkiewicz D.   Rybka B.   Boguslawska-Jaworska J.  

Transplantation Proceedings, Vol. 32, Iss. 6, 2000-09 ,pp. : 1409-1411

Elsevier

Access to resources Recommend Favorite

Effective ex vivo generation of megakaryocytic cells from mobilized peripheral blood CD34 + cells with stem cell factor and promegapoietin

By Kratz-Albers K.   Scheding S.   Mohle R.   Buhring H.J.   Baum C.M.   Mc Kearn J.P.   Buchner T.   Kanz L.   Brugger W.  

Experimental Hematology, Vol. 28, Iss. 3, 2000-03 ,pp. : 335-346

Elsevier

Access to resources Recommend Favorite